Transplasma membrane electron transport in Leishmania donovani promastigotes

The Journal of Eukaryotic Microbiology
G Datta, Tanmoy Bera

Abstract

Leishmania donovani promastigotes are capable of reducing certain electron acceptors with redox potential at pH 7 down to -125 mV; outside the plasma membrane promastigotes can reduce ferricyanide. Ferricyanide has been used as an artificial electron acceptor probe for studying the mechanism of transplasma membrane electron transport. Transmembrane ferricyanide reduction by L. donovani promastigotes was not inhibited by such mitochondrial inhibitors as antimycin A or cyanide, but it responded to inhibitors of glycolysis. Transmembrane ferricyanide reduction by Leishmania appears to involve a plasma membrane electron transport chain dissimilar to that of hepatocyte cells. As with other cells, transmembrane electron transport is associated with proton release, which may be involved in internal pH regulation. The Leishmania transmembrane redox system differs from that of mammalian cells in being 4-fold less sensitive to chloroquine and 12-fold more sensitive to niclosamide. Sensitivities to these drugs suggest that transplasma membrane electron transport and associated proton pumping may be targets for the drugs used against leishmaniasis.

References

Sep 27, 1976·Biochimica Et Biophysica Acta·G C Hill
Jul 1, 1992·The American Journal of Tropical Medicine and Hygiene·M GroglE D Franke
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·I L SunH Löw
Aug 14, 1992·Biochimica Et Biophysica Acta·P R van IwaardenW N Konings
Jan 31, 1989·Biochemical and Biophysical Research Communications·M Fry
May 1, 1988·Molecular and Biochemical Parasitology·R A Galbraith, M J McElrath
Oct 1, 1986·Annals of Tropical Medicine and Parasitology·J el-OnL F Schnur
Aug 1, 1985·Biochimica Et Biophysica Acta·F L CraneH Löw
Feb 26, 1986·Biochemical and Biophysical Research Communications·P NavasF L Crane
Jan 10, 1985·Biochimica Et Biophysica Acta·R BarrF L Crane
Sep 1, 1985·Molecular and Biochemical Parasitology·C S Chang, K P Chang
Nov 29, 1985·Science·E L HewlettD M Dwyer
Jun 28, 1973·Biochimica Et Biophysica Acta·G C Hill, G A Cross
Nov 6, 1984·Biochimica Et Biophysica Acta·P M McLoughlinF L Crane
Dec 1, 1984·Journal of Bioenergetics and Biomembranes·I L SunH Löw
Oct 14, 1983·Biochemical and Biophysical Research Communications·I L SunC Grebing
Jun 1, 1982·Journal of Bioenergetics and Biomembranes·F L CraneH Löw
Aug 20, 1993·Biochimica Et Biophysica Acta·R Stocker, C Suarna
Jan 1, 1997·Molecular Aspects of Medicine·F L Crane, P Navas
Oct 8, 1999·Lancet·B L Herwaldt
Dec 1, 1963·Analytical Biochemistry·M AVRON, N SHAVIT
Nov 29, 1985·Science·D Zilberstein, D M Dwyer
Jul 1, 1946·The Biochemical Journal·L A STOCKEN, R H S THOMPSON
Dec 1, 1969·The Journal of Membrane Biology·R K Mishra, H Passow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here